A billionaire couple is pumping money into the drug pricing debate. Can they loosen pharma’s grip?

Aaron Dorfman — president and CEO of the National Committee for Responsive Philanthropy, a left-leaning watchdog group — sees Michael Bloomberg as the Arnolds’ closest cousin. They both worship data. They both tend to weave together political and philanthropic spending. And, Dorfman said, “both of them sometimes annoy people on both the left and the right.”

Read the entire article in STAT.